ALBO
Albireo Pharma Inc
ALBO
ALBO
Delisted
ALBO was delisted on the 2nd of March, 2023.
69 hedge funds and large institutions have $181M invested in Albireo Pharma Inc in 2019 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 33 increasing their positions, 13 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
80% less call options, than puts
Call options by funds: $80K | Put options by funds: $410K
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
69
Holding in Top 10
–
Calls
$80K
Puts
$410K
Top Buyers
| 1 | +$2.34M | |
| 2 | +$1.35M | |
| 3 | +$601K | |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$595K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$583K |
Top Sellers
| 1 | -$6.26M | |
| 2 | -$3.39M | |
| 3 | -$1.92M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$1.58M |
| 5 |
MWNA
Marshall Wace North America
New York
|
-$1.29M |